Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.

Spain has begun using a new genetic ALS therapy that targets the SOD1 mutation and may slow nerve damage in patients with this rare condition.

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.

On a late winter day, the sun seeped into Andrew Chernysh’s room inside Ottawa’s century old Saint-Vincent Hospital. It ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease-related molecular biomarkers in the eye, announced today a Phase 2 grant ...

Actor Eric Dane, best known for his roles on Grey’s Anatomy and HBO’s Euphoria, has died at 53 after battling amyotrophic ...

The producer, who worked on the likes of Freaky Friday and Cruella, passed away in his home in Toronto, his family announced on Monday.

UK health minister Ashley Dalton resigns to fight incurable Stage 4 breast cancer. Wes Streeting hails the outstanding Member ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced its participation in the American Society for Experimental ...

Viagra, a popular erectile dysfunction medication, may be the world's only existing treatment against Alzheimer's disease, ...

Eliana Merle Barclays Bank PLC, Research Division. Great. Good afternoon, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Very happy to have Ionis here wi ...